CTRI/2021/07/034552已完成2 期
evetiracetam versus valproate as second line antiepileptic for management of status epilepticus in chidren.
Pandit BDSharma UHSRPGIMS ROHTAK0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children aged 3 years to 14 years with convulsive status epilepticus (clonic, tonic, tonic clonic, focal or generalised) who are neurologically normal prior to current illness will be enrolled.
排除标准
- •Acute or chronic liver disease or kidney disease.
- •Children with global developmental delay or intellectual disability.
- •Severe protein energy malnutrition.
- •Patients who have received the study drug prior to presentation in emergency department
研究者
相似试验
招募中
4 期
Comparison of levetiracetam and phenytoin in newborns with refractory seizuresCTRI/2024/02/062227All India Institute of Medical Sciences, Rishikesh
已完成
不适用
A study comparing Levetiracetam and Valproic Acid in preventing seizure in children diagnosed with neurocystcercosis.CTRI/2019/01/017368Dr Abhinav Aggarwal50
招募中
3 期
Efficacy of Levetiracetam In pedatrics migrain headacheMigraineIRCT20160802029171N3Hamedan University of Medical Sciences39
尚未招募
3 期
A clinical trial to study the effectiveness of Perampanel compared to Levetiracetam as first line anti-seizure drug in adult patients with new onset focal seizuresCTRI/2024/03/064453AIIMS Bhubaneswar
已完成
2 期
Effect of levetiracetam and sodium valproate versus sodium valproate alone on epileptiform discharges in electroencephalogram in interictal phase in children with epilepsyEpilepsy.Epilepsy and recurrent seizuresIRCT20120215009014N246Hamedan University of Medical Sciences42